Skip to main content
SpringerLink
Log in

Polyclonal predominance of concurrently producing OXA-23 and OXA-58 carbapenem-resistant Acinetobacter baumannii strains in a pediatric intensive care unit

  • Short Communication
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

We report a predominance (64.7%) of polyclonal carbapenem-resistant Acinetobacter baumannii (CRAB) strains concurrently producing OXA-23 and OXA-58 carbapenemases in a pediatric intensive care unit in an endemic area. This is the first report of emergence of such double-OXA CRAB strains in a single unit worldwide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Henig O, Weber G, Hoshen MB, Paul M, German L, Neuberger A, Gluzman I, Berlin A, Shapira C, Balicer RD (2015) Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case-control study. Eur J Clin Microbiol Infect Dis 34(10):2063–2068. https://doi.org/10.1007/s10096-015-2452-4

    Article  CAS  PubMed  Google Scholar 

  2. Russo A, Giuliano S, Ceccarelli G, Alessandri F, Giordano A, Brunetti G, Venditti M (2018) Comparison of septic shock due to multidrug-resistant Acinetobacter baumannii or Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit patients. Antimicrob Agents Chemother. https://doi.org/10.1128/AAC.02562-17

    Article  PubMed  PubMed Central  Google Scholar 

  3. Karampatakis T, Antachopoulos C, Tsakris A, Roilides E (2017) Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Greece: an extended review (2000–2015). Future Microbiol 12:801–815. https://doi.org/10.2217/fmb-2016-0200

    Article  CAS  PubMed  Google Scholar 

  4. Tsiatsiou O, Iosifidis E, Katragkou A, Dimou V, Sarafidis K, Karampatakis T, Antachopoulos C, Orfanou A, Tsakris A, Drossou-Agakidou V, Roilides E (2015) Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit. Eur J Pediatr 174(1):65–74. https://doi.org/10.1007/s00431-014-2365-8

    Article  PubMed  Google Scholar 

  5. Villalon P, Valdezate S, Medina-Pascual MJ, Carrasco G, Vindel A, Saez-Nieto JA (2013) Epidemiology of the Acinetobacter-derived cephalosporinase, carbapenem-hydrolysing oxacillinase and metallo-beta-lactamase genes, and of common insertion sequences, in epidemic clones of Acinetobacter baumannii from Spain. J Antimicrob Chemother 68(3):550–553. https://doi.org/10.1093/jac/dks448

    Article  CAS  PubMed  Google Scholar 

  6. Karampatakis T, Geladari A, Politi L, Antachopoulos C, Iosifidis E, Tsiatsiou O, Karyoti A, Papanikolaou V, Tsakris A, Roilides E (2017) Cluster-distinguishing genotypic and phenotypic diversity of carbapenem-resistant Gram-negative bacteria in solid-organ transplantation patients: a comparative study. J Med Microbiol. https://doi.org/10.1099/jmm.0.000541

    Article  PubMed  Google Scholar 

  7. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33(9):2233–2239

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Pournaras S, Dafopoulou K, Del Franco M, Zarkotou O, Dimitroulia E, Protonotariou E, Poulou A, Zarrilli R, Tsakris A, Greek Study Group on Acinetobacter Antimicrobial R (2017) Predominance of international clone 2 OXA-23-producing-Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide study. Int J Antimicrob Agents 49(6):749–753. https://doi.org/10.1016/j.ijantimicag.2017.01.028

    Article  CAS  PubMed  Google Scholar 

  9. Mathlouthi N, Ben Lamine Y, Somai R, Bouhalila-Besbes S, Bakour S, Rolain JM, Chouchani C (2018) Incidence of OXA-23 and OXA-58 carbapenemases coexpressed in clinical isolates of Acinetobacter baumannii in Tunisia. Microb Drug Resist 24(2):136–141. https://doi.org/10.1089/mdr.2016.0306

    Article  CAS  PubMed  Google Scholar 

  10. D’Arezzo S, Principe L, Capone A, Petrosillo N, Petrucca A, Visca P (2011) Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J Antimicrob Chemother 66(1):54–61. https://doi.org/10.1093/jac/dkq407

    Article  CAS  PubMed  Google Scholar 

  11. Zingg W, Holmes A, Dettenkofer M, Goetting T, Secci F, Clack L, Allegranzi B, Magiorakos AP, Pittet D, systematic review and evidence-based guidance on organization of hospital infection control programmes (SIGHT) study group (2015) Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus. Lancet Infect Dis 15(2):212–224. https://doi.org/10.1016/S1473-3099(14)70854-0

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Vassiliki Pentsioglou for epidemiological data handling and her valuable collaboration during the study.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Infectious Disease Unit, 3rd Department of Pediatrics, Medical Faculty, Aristotle University School of Health Sciences, Hippokration General Hospital, Konstantinoupoleos 49, 546 42, Thessaloniki, Greece

    Theodoros Karampatakis, Elias Iosifidis, Charalampos Antachopoulos & Emmanuel Roilides

  2. Microbiology Department, Hippokration General Hospital, Thessaloniki, Greece

    Theodoros Karampatakis, Katerina Tsergouli & Aggeliki Karyoti

  3. Microbiology Department, National and Kapodistrian University School of Medicine, Athens, Greece

    Lida Politi, Georgia Diamantopoulou & Athanassios Tsakris

  4. Infection Control Committee, Hippokration General Hospital, Thessaloniki, Greece

    Elias Iosifidis, Charalampos Antachopoulos, Aggeliki Karyoti & Emmanuel Roilides

  5. Pediatric Intensive Care Unit, Hippokration General Hospital, Thessaloniki, Greece

    Maria Sdougka

Authors
  1. Theodoros Karampatakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katerina Tsergouli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lida Politi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Georgia Diamantopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elias Iosifidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Charalampos Antachopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Aggeliki Karyoti
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Maria Sdougka
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Athanassios Tsakris
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Emmanuel Roilides
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emmanuel Roilides.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karampatakis, T., Tsergouli, K., Politi, L. et al. Polyclonal predominance of concurrently producing OXA-23 and OXA-58 carbapenem-resistant Acinetobacter baumannii strains in a pediatric intensive care unit. Mol Biol Rep 46, 3497–3500 (2019). https://doi.org/10.1007/s11033-019-04744-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-019-04744-4

Keywords

Search

Navigation